FDA Approves First Schwann Cell Transplant for Spinal Cord Injury
First FDA-Approved Autologous Schwann Cell Transplantation Performed for Acute Spinal Cord Injury Surgeons and scientists at The Miami Project to Cure Paralysis, a Center of Excellence at the University of Miami Miller School of Medicine, have completed the first Food and Drug Administration–approved transplantation of a patient’s own Schwann cells following a new spinal cord … Read more